Inovio Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.22

+0.03 (+2.52%)

As of Jul 4, 2:15 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +1,507.4% upside

Low Target $14.26

Average Target $19.61

High Target $29.32

Current Price $1.22

Current
$1.22

Target
$19.61

$14.26 $19.61 avg $29.32

Scenario Analysis

Bear Case

$14.26

1,068.9%

Low target

Base Case

$19.61

+1,507.4%

Avg target

Bull Case

$29.32

+2,303.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$2.98

-59.0% from high

52-Week Low

$1.03

+18.4% from low

Target vs 52W High

$19.61

+558.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%